Mergers & Acquisitions ·
Cronos completes acquisition of CanAdelaar for €57.5 million base price plus earnouts
CRONCronos Group Inc.
Cronos Group Inc. completed the acquisition of all outstanding shares of CanAdelaar B.V., a licensed cannabis grower in the Dutch Controlled Cannabis Supply Chain Experiment, on October 15, 2026. The transaction carries a base purchase price of €57.5 million, subject to adjustments, plus contingent cash consideration equal to 50% of CanAdelaar’s Normalized EBITDA for 2026 and 2027. The company waived closing conditions via an addendum and treated a proposed €12.5 million environmental penalty as indebtedness deducted from the purchase price. This acquisition establishes Cronos’ European platform with leading market share in the Netherlands' adult-use cannabis pilot program. Cronos Group Inc. is a global cannabis company focused on scaling consumer goods products through R&D and innovation.